Evidence map›Paper›PMID 36093298›Full record

ArticleEuropean journal of case reports in internal medicine2022

Pulmonary Nocardiosis as an Opportunistic Infection in COVID-19.

Marc Laplace, Thomas Flamand, Ciprian Ion, Simon Gravier, Mahsa Mohseni Zadeh, Dominique Debriel, Olivier Augereau, Guillaume Gregorowicz, Martin Martinot

Open access · goldAbstract read
In one paragraph

Article in European journal of case reports in internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. First Documented Case of Pneumonia withInfection and drug resistance · 2025
    Article
  2. Review
  3. Article
  4. Pulmonary nocardiosis after covid-19 infection: case report and literature review.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marc LaplaceDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Thomas FlamandDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Ciprian IonDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Simon GravierDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Mahsa Mohseni ZadehDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Dominique DebrielDepartment of Microbiology, Hôpitaux Civils de Colmar, Colmar, France.
Olivier AugereauDepartment of Microbiology, Hôpitaux Civils de Colmar, Colmar, France.
Guillaume GregorowiczDepartment of Microbiology, Hôpitaux Civils de Colmar, Colmar, France.
Martin MartinotDepartment of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France.
Hopitaux Civils de Colmar · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary bacterial pneumonia infection is frequent in COVID-19 patients. LEARNING POINTS:

Indexed as

COVID-19Nocardia cyariacigerogicanocardiosisopportunistic infectionSARS-CoV-2

Identifiers

PMID36093298
PMCPMC9451518
OpenAlexW4292714698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.